Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-25-014925
Filing Date
2025-04-22
Accepted
2025-04-22 16:34:30
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20045184x2.htm DEFA14A 12113
2 ny20045184x2_nc01.jpg GRAPHIC 124373
3 ny20045184x2_nc02.jpg GRAPHIC 88210
  Complete submission text file 0001140361-25-014925.txt   306168
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39630 | Film No.: 25858161
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)